LysoPC is produced by lecithin cholesterol acyl transferase (LCAT) and phospholipase A2 (PLA2) enzyme-catalyzed hydrolysis of the fatty acid ester, which is responsible for cell proliferation, tumor cell infiltration, and inflammatory responses [23, 24]. The gene discussed is LCAT; the disease is neoplasm.